Classification
- Anatomical main groupSSensory organs
- Therapeutic subgroupS01Ophthalmologicals
- Pharmacological subgroupS01G
- Chemical subgroupS01GA
- Chemical substanceS01GA01Naphazoline
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Brazil
Anvisa · 135 registrations
- Ad SoroCifarma Científica Farmacêutica Ltda
- cloridrato de nafazolinaEms S/A
- Cloridrato de NafazolinaBelfar Ltda
- cloridrato de nafazolinaLaboratório Globo SA
Canada
Health Canada · 40 registrations
At a glance
- ATC code
- S01GA01
- ATC group
- Sensory organs
- Registers
- 9
- Historical lists
- 1
- Registrations
- 219
- With their own page
- 69
- Companies
- 133
All medicines with Naphazoline
Human medicines from every register that match Naphazoline by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
219 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Naphazoline Hydrochloride and Pheniramine MaleateCombination | United States | 0.025%; 0.3%, 0.02675%; 0.315% | solution/drops | Marketed | Altaire Pharms INC |
| Naphazoline Hydrochloride | United States | 0.1% | solution/drops | Not marketed | Rising |
| Odan-Naphazoline | Canada | 0.1 % | Solution | Not marketed | Odan Laboratoriesltd |
| Naphcon-ACombination | United States | 0.025%; 0.3% | solution/drops | Marketed | Alcon |
| VisineCombination | United States | 0.025%; 0.3% | solution/drops | Marketed | Kenvue Brands |
| Opcon-ACombination | United States | 0.02675%; 0.315% | solution/drops | Marketed | Bausch and Lomb |
| Naphcon Forte | United States | 0.1% | solution/drops | Not marketed | Alcon |
| Nafazair | United States | 0.1% | solution/drops | Not marketed | Bausch and Lomb |
| Albalon | United States | 0.1% | solution/drops | Not marketed | Allergan |
| Opcon | United States | 0.1% | solution/drops | Not marketed | Bausch and Lomb |
| Vasocon | United States | 0.1% | solution/drops | Not marketed | Novartis |
| Naphcon ACombination | Canada | 0.025 % + 0.3 % | Solution | Marketed | Alcon Canada INC |
| Nafazol | Serbia | 0.5mg/mL | kapi za nos, rastvor | Authorised | Hemofarm Ad VRŠAc |
| Nafazol | Serbia | 1mg/mL | kapi za nos, rastvor | Authorised | Hemofarm Ad VRŠAc |
| Cloridrato de Nafazolina | Brazil | Authorised | Belfar Ltda | ||
| cloridrato de nafazolina | Brazil | Authorised | Laboratório Globo SA | ||
| cloridrato de nafazolina | Brazil | Authorised | Ems S/A | ||
| cloridrato de nafazolina | Brazil | Authorised | Airela Indústria Farmacêutica Ltda. | ||
| CENTILUX 0,25 mg/ml COLIRIO EN SOLUCION | Spain | 0,25 mg | colirio en solución | Marketed | Reva Health Europe S.L. |
| Optialerg 5 MG/ML + 0,25 MG/ML Colirio en SolucionCombination | Spain | 5,00 mg/ml + 0,25 mg/ml | colirio en solución | Marketed | Laboratorios Cinfa S.A. |
| ALERGOFTAL 0,25 mg/ml+ 5 mg/ml COLIRIO EN SOLUCIONCombination | Spain | 0,25 mg + 5 mg | colirio en solución | Marketed | Reva Health Europe S.L. |
| Colirofta Anestesico 5 MG/ML + 0,5 MG/ML Colirio en SolucionCombination | Spain | 0,5 mg + 5 mg | colirio en solución | Marketed | Alcon Healthcare S.A. |
| NeonazolCombination | Brazil | Authorised | Nativita Ind. Com. Ltda. | ||
| OJOSBEL GOTAS OCULARES, 0,30 mg/0,08 ml Colirio en soluciónCombination | Spain | 0,3 mg + 0,08 ml | colirio en solución | Marketed | Dermofarm S.A.U. |
| Cloridrato de Nafazolina+Maleato de FeniraminaCombination | Brazil | Authorised | Geolab Indústria Farmacêutica S/A |